Anti

1. Anti-Retroviral drugs Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast The global anti-retroviral drugsmarket size is expected to expand at a robust CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising burden of HIV, increasing investment in research and development and growing demand for of new and efficient drugs. Antiretroviral drugs (ARV) are used to treat HIV. Approximately 37.9 million people worldwide are infected with HIV/AIDS. In 2018, an estimated 1.7 million people worldwide were infected with HIV. For unstable HIV strains, antiretroviral therapy can inhibit about 80% of HIV replication. Market Trends, Drivers, Restraints, and Opportunities Increasing incidence of HIV is expected to boost the market growth during the forecast period. Rapid growth of the healthcare industry is one of the major factors boosting the market growth in the coming years. Increasing geriatric population and availability of products being developed for the treatment of HIVare anticipated to drive the market growth during forecast period. High price of anti-retroviral drugs and presence of generic drugs are expected to hamper the market growth. Rising awareness about drugs treatment and initiatives taken by government and other non- profit organizations by launching educational programs can proliferate the growth of the market. Rising R&D investment and ongoing development of new efficient drugs to reduce the therapy cost are expected to create immense opportunities for the market players in the projected timeline.      

2. Sample - https://growthmarketreports.com/request-sample/1978 Market Segment Insights Multi-class combination products segment is projected to represent a major market share Basedon drug classes, the market is segmented into integrase inhibitor, protease inhibitor, multi-class combination products, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, and others. The multi-class combination products segment is expected to represent a key market share during the forecast period owing to the rising number of multi-type combination products due to the increasing burden of HIV and the approval of new drugs. According to the World Health Organization, about 770,000 people died of HIV in 2018. Many companies are focusing on development of innovative ARV therapy products to maintain competitive advantage and expand into new regional markets. Additionally, increasing funding for ARV drug development is expected to drive the growth of the market segment. The nucleoside reverse transcriptase inhibitors segment and non-nucleoside reverse transcriptase inhibitors segment are anticipated to expand at a rapid pace during the forecast period. Some of the most widely used drugs in resource-limited areas use reverse transcriptase inhibitors due to the low genetic barriers. Moreover, nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors are used to combat HIV and hepatitis infections through highly effective ARV therapy. Inquiry- https://growthmarketreports.com/enquiry-before-buying/1978 Competitive Landscape Key players competing in the anti-retroviral drugs market include ViiV Healthcare, Merck & Co Inc., Gilead Sciences Inc., Bristol-Myers Squibb Company, and Boehringer Ingelheim International GmbH. Major players are involved in the development of new ARV drugs, especially drugs for the treatment of HIV. For instance, Gilead Sciences' Phase II clinical trial product GS-9131 is being developed for the treatment of HIV with reverse nucleosides. About Growth Market Reports: GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact:

3. Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports.com Web: https://growthmarketreports.com Follow Us: LinkedIn | Twitter